Cargando…

Drug Treatment in Older People before and after the Transition to a Multi-Dose Drug Dispensing System–A Longitudinal Analysis

BACKGROUND: An association has been found between multi-dose drug dispensing (MDD) and use of many drugs. The aim of this study was to investigate the nature of this association, by performing a longitudinal analysis of the drug treatment before and after the transition to MDD. METHODS: Inclusion cr...

Descripción completa

Detalles Bibliográficos
Autores principales: Wallerstedt, Susanna M., Fastbom, Johan, Johnell, Kristina, Sjöberg, Christina, Landahl, Sten, Sundström, Anders
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3691131/
https://www.ncbi.nlm.nih.gov/pubmed/23826197
http://dx.doi.org/10.1371/journal.pone.0067088
_version_ 1782274419995967488
author Wallerstedt, Susanna M.
Fastbom, Johan
Johnell, Kristina
Sjöberg, Christina
Landahl, Sten
Sundström, Anders
author_facet Wallerstedt, Susanna M.
Fastbom, Johan
Johnell, Kristina
Sjöberg, Christina
Landahl, Sten
Sundström, Anders
author_sort Wallerstedt, Susanna M.
collection PubMed
description BACKGROUND: An association has been found between multi-dose drug dispensing (MDD) and use of many drugs. The aim of this study was to investigate the nature of this association, by performing a longitudinal analysis of the drug treatment before and after the transition to MDD. METHODS: Inclusion critera in this register-based study were inhabitants in Region Västra Götaland, Sweden, who, at ≥65 years of age and between 1(st) July 2006 and 30(th) June 2010, filled their first MDD prescription. For each individual, prescribed drugs were estimated at three month intervals before and after (maximum 3 years, respectively) the first date of filling an MDD prescription (index date). RESULTS: A total of 30,922 individuals matched the inclusion criteria (mean age: 83.2 years; 59.9% female). There was a temporal association between the transition to MDD and an increased number of drugs: 5.4±3.9 and 7.5±3.8 unique drugs three months before and after the index date, respectively, as well as worse outcomes on several indicators of prescribing quality. When either data before or after the index date were used, a multi-level regression analysis predicted the number of drugs at the index date at 5.76 (95% confidence limits: 5.71; 5.80) and 7.15 (7.10; 7.19), respectively, for an average female individual (83.2 years, 10.8 unique diagnoses, 2.4 healthcare contacts/three months). The predicted change in the number of drugs, from three months before the index date to the index date, was greater when data before this date was used as compared with data after this date: 0.12 (0.09; 0.14) versus 0.02 (−0.01; 0.05). CONCLUSIONS: After the patients entered the MDD system, they had an increased number of drugs, more often potentially harmful drug treatment, and fewer changes in drug treatment. These findings support a causal relationship between such a system and safety concerns as regards prescribing practices.
format Online
Article
Text
id pubmed-3691131
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-36911312013-07-03 Drug Treatment in Older People before and after the Transition to a Multi-Dose Drug Dispensing System–A Longitudinal Analysis Wallerstedt, Susanna M. Fastbom, Johan Johnell, Kristina Sjöberg, Christina Landahl, Sten Sundström, Anders PLoS One Research Article BACKGROUND: An association has been found between multi-dose drug dispensing (MDD) and use of many drugs. The aim of this study was to investigate the nature of this association, by performing a longitudinal analysis of the drug treatment before and after the transition to MDD. METHODS: Inclusion critera in this register-based study were inhabitants in Region Västra Götaland, Sweden, who, at ≥65 years of age and between 1(st) July 2006 and 30(th) June 2010, filled their first MDD prescription. For each individual, prescribed drugs were estimated at three month intervals before and after (maximum 3 years, respectively) the first date of filling an MDD prescription (index date). RESULTS: A total of 30,922 individuals matched the inclusion criteria (mean age: 83.2 years; 59.9% female). There was a temporal association between the transition to MDD and an increased number of drugs: 5.4±3.9 and 7.5±3.8 unique drugs three months before and after the index date, respectively, as well as worse outcomes on several indicators of prescribing quality. When either data before or after the index date were used, a multi-level regression analysis predicted the number of drugs at the index date at 5.76 (95% confidence limits: 5.71; 5.80) and 7.15 (7.10; 7.19), respectively, for an average female individual (83.2 years, 10.8 unique diagnoses, 2.4 healthcare contacts/three months). The predicted change in the number of drugs, from three months before the index date to the index date, was greater when data before this date was used as compared with data after this date: 0.12 (0.09; 0.14) versus 0.02 (−0.01; 0.05). CONCLUSIONS: After the patients entered the MDD system, they had an increased number of drugs, more often potentially harmful drug treatment, and fewer changes in drug treatment. These findings support a causal relationship between such a system and safety concerns as regards prescribing practices. Public Library of Science 2013-06-24 /pmc/articles/PMC3691131/ /pubmed/23826197 http://dx.doi.org/10.1371/journal.pone.0067088 Text en © 2013 Wallerstedt et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Wallerstedt, Susanna M.
Fastbom, Johan
Johnell, Kristina
Sjöberg, Christina
Landahl, Sten
Sundström, Anders
Drug Treatment in Older People before and after the Transition to a Multi-Dose Drug Dispensing System–A Longitudinal Analysis
title Drug Treatment in Older People before and after the Transition to a Multi-Dose Drug Dispensing System–A Longitudinal Analysis
title_full Drug Treatment in Older People before and after the Transition to a Multi-Dose Drug Dispensing System–A Longitudinal Analysis
title_fullStr Drug Treatment in Older People before and after the Transition to a Multi-Dose Drug Dispensing System–A Longitudinal Analysis
title_full_unstemmed Drug Treatment in Older People before and after the Transition to a Multi-Dose Drug Dispensing System–A Longitudinal Analysis
title_short Drug Treatment in Older People before and after the Transition to a Multi-Dose Drug Dispensing System–A Longitudinal Analysis
title_sort drug treatment in older people before and after the transition to a multi-dose drug dispensing system–a longitudinal analysis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3691131/
https://www.ncbi.nlm.nih.gov/pubmed/23826197
http://dx.doi.org/10.1371/journal.pone.0067088
work_keys_str_mv AT wallerstedtsusannam drugtreatmentinolderpeoplebeforeandafterthetransitiontoamultidosedrugdispensingsystemalongitudinalanalysis
AT fastbomjohan drugtreatmentinolderpeoplebeforeandafterthetransitiontoamultidosedrugdispensingsystemalongitudinalanalysis
AT johnellkristina drugtreatmentinolderpeoplebeforeandafterthetransitiontoamultidosedrugdispensingsystemalongitudinalanalysis
AT sjobergchristina drugtreatmentinolderpeoplebeforeandafterthetransitiontoamultidosedrugdispensingsystemalongitudinalanalysis
AT landahlsten drugtreatmentinolderpeoplebeforeandafterthetransitiontoamultidosedrugdispensingsystemalongitudinalanalysis
AT sundstromanders drugtreatmentinolderpeoplebeforeandafterthetransitiontoamultidosedrugdispensingsystemalongitudinalanalysis